Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Revlar Diagnostics logo — Developing breakthrough infectious disease diagnostic soluti...

Revlar Diagnostics

Developing breakthrough infectious disease diagnostic solutions designed for speed, sensitivity and simplicity

Founded 2019 United States Los Angeles, United States 4 employees Biotechnology, Health Care

General Information

Company Name Revlar Diagnostics
Founded Year 2019
Location United States Los Angeles, United States +1
Employees 4
Industries Biotechnology, Health Care
Social

Get notified when Revlar Diagnostics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Revlar Diagnostics

Revlar Diagnostics is a biotechnology and healthcare startup based in the United States, founded in 2019. The company's slogan, "Developing breakthrough infectious disease diagnostic solutions designed for speed, sensitivity, and simplicity," encapsulates its mission. Revlar Labs aims to revolutionize infectious disease diagnostics in both commercial and laboratory markets. Their approach includes Covid-targeted assays utilizing patented biosensors in vitro, as well as on-site and Point of Care diagnostic solutions. The company's offerings address the challenges associated with typical PCR and rapid antigen tests for COVID. By leveraging hinged peptid molecular nanoswitches, Revlar Labs has designed a better diagnostic solution that promises speed, simplicity, and sensitivity, enabling labs to scale accurate, rapid-results tests. Their CLIA LAB solutions encompass Covid-targeted assay development and High-Throughput Lab (HTL) kits. Additionally, they provide on-site Covid solutions suitable for Point of Care providers, venues, employers, and school campuses. Revlar Diagnostics presents an innovative and timely solution to the pressing need for reliable and efficient infectious disease diagnostics. Their focus on scalability, accuracy, and speed makes them a promising player in the biotechnology and healthcare industries. As of now, there's no publicly available information about their last investment, investors, or investment amount. For potential investors seeking opportunities in the infectious disease diagnostics space, Revlar Diagnostics could be an intriguing prospect. For further information, interested parties can reach out to Tony via [email protected] .

Taxonomy: Infectious Disease Diagnostics, Molecular Assays, COVID-19 Diagnostics, Point of Care Solutions, CLIA Lab, Pathology, Biosensors, High-Throughput Lab Kits, SARS-CoV-2, Rapid Diagnostics, Nanoswitches, Venues, Employers, School Campuses

No funding data available for Revlar Diagnostics yet.

Get notified when Revlar Diagnostics raises funding

Revlar Diagnostics Alternatives & Competitors

Revlar Diagnostics vs
Accel Diagnostics, LLC
Accel Diagnostics, LLC United States

Accel Diagnostics is a developer and manufacturer of blood diagnostic tests and laboratory analyzers...

Convertible Note
4 employees
Health Care, Medical Devices
Compare Revlar Diagnostics vs Accel Diagnostics, LLC
Revlar Diagnostics vs
Ativa
Ativa United States

Decoding Blood, Changing Care.

Series Unknown
20 employees
Biotechnology, Health Care
Revlar Diagnostics vs
Gather Labs
Gather Labs United States

Beverly Hills based high-complexity CLIA laboratory and medical clinic focused on Same Day Diagnosti...

Seed
1 employees
Biotechnology, Health Care

FAQ About Revlar Diagnostics

Developing breakthrough infectious disease diagnostic solutions designed for speed, sensitivity and simplicity
Revlar Diagnostics was founded in 2019.
Revlar Diagnostics is headquartered in Los Angeles, United States.
Revlar Diagnostics operates in the following industries: Biotechnology, Health Care.
Revlar Diagnostics has approximately 4 employees.
Top alternatives and competitors to Revlar Diagnostics include Accel Diagnostics, LLC, Ativa, Gather Labs, Ranbaxy Diagnostics®, LUX Diagnostics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Revlar Diagnostics and Accel Diagnostics, LLC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Revlar Diagnostics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy